Cargando…

In reply— Association of Renin-Angiotensin System Blockers with Outcomes in Patients With COVID-19

Detalles Bibliográficos
Autores principales:	Sanchis-Gomar, Fabian, Lavie, Carl J., Perez-Quilis, Carme, Henry, Brandon M., Lippi, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mayo Foundation for Medical Education and Research 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489921/ https://www.ncbi.nlm.nih.gov/pubmed/33153643 http://dx.doi.org/10.1016/j.mayocp.2020.09.011

Ejemplares similares

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Statins and other drugs: Facing COVID-19 as a vascular disease
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

In Reply — Cardiorespiratory Fitness Attenuates the Impact of Risk Factors Associated With COVID-19 Hospitalization
por: Lavie, Carl J., et al.
Publicado: (2021)

Repeated Testing in SARS-CoV-2 Infection
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Putative impact of the COVID-19 pandemic on anxiety, depression, insomnia and stress
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Association of Renin-Angiotensin System Blockers With Outcomes in Patients with COVID-19
por: Garg, Aakash, et al.
Publicado: (2020)

CT-Determined Maximum Pulmonary Artery to Ascending Aorta Diameter Ratio in Nonsevere COVID-19 Patients
por: Abosamak, Mohammed Fawzi, et al.
Publicado: (2021)

Cardiac Biomarkers in COVID-19: A Narrative Review
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Obesity and Outcomes in COVID-19: When an Epidemic and Pandemic Collide
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Estimating the burden of mental health impairment after COVID-19
por: Mattiuzzi, Camilla, et al.
Publicado: (2022)

Amiodarone in the COVID-19 Era: Treatment for Symptomatic Patients Only, or Drug to Prevent Infection?
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Cardiac Injury in COVID-19–Echoing Prognostication
por: Lavie, Carl J., et al.
Publicado: (2020)

Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis()
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Renin-angiotensin system blockers and outcomes during hydroxychloroquine treatment in patients hospitalized for COVID-19 pneumonia
por: Di Tano, Giuseppe, et al.
Publicado: (2020)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Estimating Worldwide Impact of Low Physical Activity on Risk of Developing Ischemic Heart Disease-Related Disability: An Updated Search in the 2019 Global Health Data Exchange (GHDx)
por: Lippi, Giuseppe, et al.
Publicado: (2022)

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

COVID-19: unravelling the clinical progression of nature’s virtually perfect biological weapon
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Active smoking and COVID-19: a double-edged sword
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19): the portrait of a perfect storm
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA
por: Lippi, Giuseppe, et al.
Publicado: (2022)

COVID-19 and smoking: Considerations after two years
por: Lippi, Giuseppe, et al.
Publicado: (2023)

New Molecular Targets and Lifestyle Interventions to Delay Aging Sarcopenia
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2014)

Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
por: Aggarwal, Gaurav, et al.
Publicado: (2020)

Do Antioxidant Vitamins Prevent Exercise-Induced Muscle Damage? A Systematic Review
por: Martinez-Ferran, María, et al.
Publicado: (2020)

Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection
por: Kessler, Thorsten, et al.
Publicado: (2020)

COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure
por: Siniorakis, Eftychios, et al.
Publicado: (2020)

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers improved the outcome of patients with severe COVID-19 and hypertension
por: Meng, Xiao, et al.
Publicado: (2020)

Updates on laboratory investigations in coronavirus disease 2019 (COVID-19)
por: Lippi, Giuseppe, et al.
Publicado: (2020)

SARS-CoV-2 recurrent RNA positivity after recovering from coronavirus disease 2019 (COVID-19): a meta-analysis
por: Mattiuzzi, Camilla, et al.
Publicado: (2020)

Protecting against sedentary lifestyle, left atrial enlargement and atrial fibrillation
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2022)

Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Injury, failure or success? Renin–angiotensin system inhibition in acute kidney injury
por: Ellam, Tim, et al.
Publicado: (2011)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3bkiufg2qbpj219ro2vmrhjj6u